Citation Impact
Citing Papers
Allosteric Pathways in the PPARγ-RXRα nuclear receptor complex
2016
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Structural basis for the activation of PPARγ by oxidized fatty acids
2008
Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges
2020
Polyacetylenes from Notopterygium incisum–New Selective Partial Agonists of Peroxisome Proliferator-Activated Receptor-Gamma
2013
Cancer drug resistance: an evolving paradigm
2013 Standout
CLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology
2008
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Key role of the REC lobe during CRISPR–Cas9 activation by ‘sensing’, ‘regulating’, and ‘locking’ the catalytic HNH domain
2018 StandoutNobel
Peroxisome proliferator-activated receptor structures: Ligand specificity, molecular switch and interactions with regulators
2007
Dietary α-Eleostearic Acid Ameliorates Experimental Inflammatory Bowel Disease in Mice by Activating Peroxisome Proliferator-Activated Receptor-γ
2011
Pharmacophore-driven identification of PPARγ agonists from natural sources
2010
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
2018 Standout
Structural Insight into PPARγ Activation Through Covalent Modification with Endogenous Fatty Acids
2008
Sulphonamides: Deserving class as MMP inhibitors?
2012
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
2013 Standout
Chloride channels as drug targets
2008
Endosome maturation
2011 Standout
Sensors and regulators of intracellular pH
2009 Standout
Structural insights for the design of new PPARgamma partial agonists with high binding affinity and low transactivation activity
2011
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
N-Acetylfarnesylcysteine Is a Novel Class of Peroxisome Proliferator-activated Receptor γ Ligand with Partial and Full Agonist Activity in Vitro and in Vivo
2011
3d Transition Metals for C–H Activation
2018 Standout
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
2017 Standout
Hybrid assemblies of ATP-sensitive K + channels determine their muscle-type-dependent biophysical and pharmacological properties
2006
An efficient electrochemical synthesis of β-keto sulfones from sulfinates and 1,3-dicarbonyl compounds
2015
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Synthesis of 2-aminobenzoxazoles via copper-catalyzed electrophilic amination of benzoxazoles with O-benzoyl hydroxylamines
2013
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
2015 Standout
Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design
2012
Discovery of 1,1′-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors
2015
Catalyst‐ and Reagent‐Free Electrochemical Azole C−H Amination
2018
Works of Antonio Laghezza being referenced
Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth
2017
Dualistic actions of cromakalim and new potent 2H‐1,4‐benzoxazine derivatives on the native skeletal muscle KATP channel
2003
Structural requisites of 2‐(p‐chlorophenoxy)propionic acid analogues for activity on native rat skeletal muscle chloride conductance and on heterologously expressed CLC‐1
2003
Synthesis, SAR, and Biological Evaluation of α‐Sulfonylphosphonic Acids as Selective Matrix Metalloproteinase Inhibitors
2009
Resveratrol and Its Metabolites Bind to PPARs
2014
Biphenyl Sulfonylamino Methyl Bisphosphonic Acids as Inhibitors of Matrix Metalloproteinases and Bone Resorption
2011
Insights into the Mechanism of Partial Agonism
2007
Structural Insight into Peroxisome Proliferator-Activated Receptor γ Binding of Two Ureidofibrate-Like Enantiomers by Molecular Dynamics, Cofactor Interaction Analysis, and Site-Directed Mutagenesis
2010
ChemInform Abstract: Convenient Synthesis of Some 3‐Phenyl‐1‐benzofuran‐2‐carboxylic Acid Derivatives as New Potential Inhibitors of CLC‐Kb Channels.
2011
Synthesis, Biological Evaluation, and Molecular Modeling Investigation of New Chiral Fibrates with PPARα and PPARγ Agonist Activity
2005
Convenient Synthesis of Some 3-Phenyl-1-benzofuran-2-carboxylic Acid Derivatives as New Potential Inhibitors of CLC-Kb Channels
2010
Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design
2008
Molecular switch for CLC-K Cl − channel block/activation: Optimal pharmacophoric requirements towards high-affinity ligands
2008